145 related articles for article (PubMed ID: 19010935)
1. Heparin binding epidermal growth factor-like growth factor and PD169316 prevent apoptosis in mouse embryonic stem cells.
Krishnamoorthy M; Heimburg-Molinaro J; Bargo AM; Nash RJ; Nash RJ
J Biochem; 2009 Feb; 145(2):177-84. PubMed ID: 19010935
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
Nakamura K; Iwamoto R; Mekada E
J Cell Biol; 1995 Jun; 129(6):1691-705. PubMed ID: 7790364
[TBL] [Abstract][Full Text] [Related]
3. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
Nakamura K; Mitamura T; Takahashi T; Kobayashi T; Mekada E
J Biol Chem; 2000 Jun; 275(24):18284-90. PubMed ID: 10749879
[TBL] [Abstract][Full Text] [Related]
4. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
Seo M; Lee MJ; Heo JH; Lee YI; Kim Y; Kim SY; Lee ES; Juhnn YS
J Biol Chem; 2007 Aug; 282(34):24720-30. PubMed ID: 17548351
[TBL] [Abstract][Full Text] [Related]
5. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
Murayama Y; Miyagawa J; Shinomura Y; Kanayama S; Isozaki K; Yamamori K; Mizuno H; Ishiguro S; Kiyohara T; Miyazaki Y; Taniguchi N; Higashiyama S; Matsuzawa Y
Int J Cancer; 2002 Apr; 98(4):505-13. PubMed ID: 11920609
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.
Takemura T; Hino S; Murata Y; Yanagida H; Okada M; Yoshioka K; Harris RC
Kidney Int; 1999 Jan; 55(1):71-81. PubMed ID: 9893115
[TBL] [Abstract][Full Text] [Related]
7. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
[TBL] [Abstract][Full Text] [Related]
8. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
Nishida M; Miyagawa J; Yamashita S; Higashiyama S; Nakata A; Ouchi N; Tamura R; Yamamori K; Kihara S; Taniguchi N; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1236-43. PubMed ID: 10807738
[TBL] [Abstract][Full Text] [Related]
9. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
Higashiyama S; Iwamoto R; Goishi K; Raab G; Taniguchi N; Klagsbrun M; Mekada E
J Cell Biol; 1995 Mar; 128(5):929-38. PubMed ID: 7876316
[TBL] [Abstract][Full Text] [Related]
10. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain.
Sakuma T; Higashiyama S; Hosoe S; Hayashi S; Taniguchi N
J Biochem; 1997 Aug; 122(2):474-80. PubMed ID: 9378729
[TBL] [Abstract][Full Text] [Related]
11. Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages.
Ouchi N; Kihara S; Yamashita S; Higashiyama S; Nakagawa T; Shimomura I; Funahashi T; Kameda-Takemura K; Kawata S; Taniguchi N; Matsuzawa Y
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):923-8. PubMed ID: 9396739
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
[TBL] [Abstract][Full Text] [Related]
13. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor.
Takemura T; Hino S; Kuwajima H; Yanagida H; Okada M; Nagata M; Sasaki S; Barasch J; Harris RC; Yoshioka K
J Am Soc Nephrol; 2001 May; 12(5):964-972. PubMed ID: 11316855
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
15. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
Shishido Y; Sharma KD; Higashiyama S; Klagsbrun M; Mekada E
J Biol Chem; 1995 Dec; 270(49):29578-85. PubMed ID: 7494001
[TBL] [Abstract][Full Text] [Related]
16. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
Inui S; Higashiyama S; Hashimoto K; Higashiyama M; Yoshikawa K; Taniguchi N
J Cell Physiol; 1997 Jun; 171(3):291-8. PubMed ID: 9180898
[TBL] [Abstract][Full Text] [Related]
17. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching.
Takemura T; Hino S; Okada M; Murata Y; Yanagida H; Ikeda M; Yoshioka K; Harris RC
Kidney Int; 2002 Jun; 61(6):1968-79. PubMed ID: 12028437
[TBL] [Abstract][Full Text] [Related]
18. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor.
Iwamoto R; Handa K; Mekada E
J Biol Chem; 1999 Sep; 274(36):25906-12. PubMed ID: 10464334
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) protected intestinal ischemia-reperfusion injury through JNK and p38/MAPK-dependent pathway for anti-apoptosis.
Ming YC; Chao HC; Chu SM; Luo CC
Pediatr Neonatol; 2019 Jun; 60(3):332-336. PubMed ID: 30455099
[TBL] [Abstract][Full Text] [Related]
20. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
